Clinical Trial Update: A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Nexvax-2 in patients with celiac disease to assess safety, efficacy, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Nexvax-2

Snippet

Sponsor: ImmusanT, Inc. | Conditions: Celiac Disease, Celiac | Phase 2 | Status: UNKNOWN